Radiant Innovation Inc. (TPEX:3373)
19.65
+0.55 (2.88%)
Sep 18, 2025, 1:30 PM CST
Radiant Innovation Revenue
Radiant Innovation had revenue of 100.81M TWD in the quarter ending June 30, 2025, a decrease of -5.24%. This brings the company's revenue in the last twelve months to 418.70M, up 6.66% year-over-year. In the year 2024, Radiant Innovation had annual revenue of 420.53M with 0.49% growth.
Revenue (ttm)
418.70M
Revenue Growth
+6.66%
P/S Ratio
2.23
Revenue / Employee
n/a
Employees
n/a
Market Cap
935.71M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 420.53M | 2.03M | 0.49% |
Dec 31, 2023 | 418.50M | -146.06M | -25.87% |
Dec 31, 2022 | 564.56M | -420.49M | -42.69% |
Dec 31, 2021 | 985.04M | -1.63B | -62.36% |
Dec 31, 2020 | 2.62B | 1.83B | 233.38% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lumosa Therapeutics | 37.25M |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Polaris Group | 64.02M |
Center Laboratories | 1.60B |